ArticleScientific reports2025
Quality comparison of Gastrodia elata grown using artificial mushroom cultivation kits and traditional wood-based cultivation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Facing wild resource depletion, artificial cultivation of Gastrodia elata (G. elata) is crucial. This study compared traditional wood (TW) and artificial mushroom grow kits (AM) cultivation impacts on G. elata quality. High-Performance Liquid Chromatography (HPLC) showed similar gastrodin levels, but TW G. elata had higher 4-hydroxybenzylalcohol (0.05-0.16%) than AM G. elata (0.02-0.04%), while AM G. elata had more parishin E (0.90-1.58%) than TW G. elata (0.68-0.96%). AM G. elata exhibited elevated crude protein (8.86-10.57%) and stable total polysaccharides (38.91-39.90%), contrasting with TW G. elata. Umami amino acids (glutamic acid, aspartic acid) were significantly higher in AM G. elata (6.03-7.37 mg/g, 1.24-1.88 mg/g). Headspace Solid-Phase Microextraction coupled with Gas Chromatography-Mass Spectrometry (HS-SPME-GC-MS) identified thirteen differential volatile compounds, with AM G. elata showing increased esters and aromatics like (2S,3S)-2,3-butanediol and tetramethylpyrazine, contributing sweet/meaty notes. TW G. elata was rich in decanal and (2E,4E)-deca-2,4-dienal, yielding citrus/chicken-like aromas. AM cultivation enhances G. elata's nutritional and aromatic profiles, supporting its refined application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.